Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred? Editorial Article uri icon

Overview

publication date

  • March 2, 2020

Research

keywords

  • Neoadjuvant Therapy
  • Pancreatic Neoplasms

Identity

PubMed Central ID

  • PMC7255981

Scopus Document Identifier

  • 85085630342

Digital Object Identifier (DOI)

  • 10.1200/JCO.19.03318

PubMed ID

  • 32119598

Additional Document Info

volume

  • 38

issue

  • 16